NCGC00024710-03

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

32 Suppliers, 17 USDMF, 10 CEP/COS, 1 JDMF, 6 EU WC, 2 KDMF, 14 NDC API, 14 Listed Suppliers

DEVELOPMENTS

1 Drug(s) in Development

1 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

3 Suppliers

3 Suppliers

DOSSIERs // Finished Dosage Forms

159 Dossiers, 113 FDA Orange Book, 22 Europe, 10 Canada, 6 South Africa, 8 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 120MG, TABLET, EXTENDED RELEASE;ORAL - 180MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 240MG, CAPSULE, EXTENDED RELEASE;ORAL - 120MG, CAPSULE, EXTENDED RELEASE;ORAL - 180MG, CAPSULE, EXTENDED RELEASE;ORAL - 240MG, CAPSULE, EXTENDED RELEASE;ORAL - 360MG, CAPSULE, EXTENDED RELEASE;ORAL - 100MG, CAPSULE, EXTENDED RELEASE;ORAL - 200MG, CAPSULE, EXTENDED RELEASE;ORAL - 300MG

RELATED EXCIPIENT COMPANIES

Suppliers, 38 Kerry, 34 BASF, 23 Roquette, 16 Ideal Cures Pvt Ltd, 16 Corel Pharma Chem, 14 Seppic, 13 Gangwal Chemicals, 13 Microlex e.U, 12 Sigachi Industries, 11 Gangwal Healthcare, 11 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 Actylis, 7 DFE Pharma, 6 SPI Pharma, 6 Lonza Capsugel, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 5 Prachin Chemical, 5 Pharmatrans-Sanaq, 5 Nanjing Well Pharmaceutical, 5 Boai NKY Pharmaceuticals Ltd, 4 Vasa Pharmachem, 4 ACG Worldwide, 4 Ingredion Pharma Solutions, 4 Kima Chemical, 3 The Dow Chemical Company, 3 Jai Radhe Sales, 3 Evonik, 3 Alcedo Pharmachem, 3 DKSH, 2 Seqens, 2 Finar, 2 Qualicaps, 2 Rochem International Inc, 2 Nomisma Healthcare, 2 Ulanqab Kema New Material, 1 Aeon Procare, 1 Vertellus, 1 Bioplus Life Sciences, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Doshion Polyscience, 1 Clariant, 1 NEWEDGE Overseas, 1 Chynops Pharma, 1 Pharm-RX Chemical, 1 Nanjing Bold Chemical, 1 Pfanstiehl, 1 Minakem

EXCIPIENTS BY APPLICATIONS

75 Coating Systems & Additives, 73 Fillers, Diluents & Binders, 49 Controlled & Modified Release, 47 Disintegrants & Superdisintegrants, 39 Direct Compression, 32 Solubilizers, 31 Granulation, 27 Thickeners and Stabilizers, 22 Taste Masking, 21 Lubricants & Glidants, 17 Parenteral, 16 Film Formers & Plasticizers, 15 Topical, 13 Co-Processed Excipients, 12 Chewable & Orodispersible Aids, 9 Empty Capsules, 7 Emulsifying Agents, 6 API Stability Enhancers, 5 Rheology Modifiers, 4 Vegetarian Capsules, 3 Surfactant & Foaming Agents, 2 Coloring Agents

GLOBAL SALES INFORMATION

52 US Medicaid Prescriptions, 36 Finished Drug Prices

MARKET PLACE

13 APIs, 1 DOSSIERS // FDF

PATENTS

4 Health Canada Patents

4 Health Canada Patents

ANALYTICAL SOLUTION(s)

4 EDQM Standards, 1 USP Standards, 1 Other Ref. Standards

DIGITAL CONTENT

18 News

18 News

Information, Expiry & Status of Health Canada Patents covering NCGC00024710-03.

NCGC00024710-03

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

32 Suppliers

17 USDMF

10 CEP/COS

1 JDMF

6 EU WC

2 KDMF

14 NDC API

14 Listed Suppliers

DEVELOPMENTS

1 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

3 Suppliers

DOSSIERs // Finished Dosage Forms

159 Dossiers

113 FDA Orange Book

22 Europe

10 Canada

6 South Africa

8 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 120MG

TABLET, EXTENDED RELEASE;ORAL - 180MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 240MG

CAPSULE, EXTENDED RELEASE;ORAL - 120MG

CAPSULE, EXTENDED RELEASE;ORAL - 180MG

CAPSULE, EXTENDED RELEASE;ORAL - 240MG

CAPSULE, EXTENDED RELEASE;ORAL - 360MG

CAPSULE, EXTENDED RELEASE;ORAL - 100MG

CAPSULE, EXTENDED RELEASE;ORAL - 200MG

CAPSULE, EXTENDED RELEASE;ORAL - 300MG

RELATED EXCIPIENT COMPANIES

Suppliers

38 Kerry

34 BASF

23 Roquette

16 Ideal Cures Pvt Ltd

16 Corel Pharma Chem

14 Seppic

13 Gangwal Chemicals

13 Microlex e.U

12 Sigachi Industries

11 Gangwal Healthcare

11 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

10 Actylis

7 DFE Pharma

6 SPI Pharma

6 Lonza Capsugel

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

5 Prachin Chemical

5 Pharmatrans-Sanaq

5 Nanjing Well Pharmaceutical

5 Boai NKY Pharmaceuticals Ltd

4 Vasa Pharmachem

4 ACG Worldwide

4 Ingredion Pharma Solutions

4 Kima Chemical

3 The Dow Chemical Company

3 Jai Radhe Sales

3 Evonik

3 Alcedo Pharmachem

3 DKSH

2 Seqens

2 Finar

2 Qualicaps

2 Rochem International Inc

2 Nomisma Healthcare

2 Ulanqab Kema New Material

TABLET;ORAL - 120MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 80MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 180MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons